Markus Ollert

Title: The Innovations of Markus Ollert

Introduction

Markus Ollert is a notable inventor based in Gauting, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the area of vaccine development. His work focuses on enhancing the efficacy of vaccines through innovative approaches.

Latest Patents

Markus Ollert holds 1 patent for his invention titled "Controlled activation of complement components for use as endogenous adjuvant." This invention relates to a pharmaceutical composition that includes a therapeutically effective dose of at least one recombinant human C3-derivative and at least one antigen for vaccination. This innovative approach aims to improve the immune response to vaccines.

Career Highlights

Throughout his career, Ollert has worked with several prominent organizations. He has been associated with Pls-design GmbH, where he contributed to various projects in the pharmaceutical sector. Additionally, he has worked at Klinikum Rechts Der Isar Der Technischen Universität München, further enhancing his expertise in medical research and development.

Collaborations

Markus Ollert has collaborated with notable colleagues in his field, including Reinhard Bredehorst and Thomas Grunwald. These partnerships have allowed him to expand his research and contribute to advancements in vaccine technology.

Conclusion

Markus Ollert's innovative work in the pharmaceutical industry, particularly in vaccine development, showcases his commitment to improving public health. His contributions through patents and collaborations highlight the importance of innovation in medicine.